Amneal Pharmaceuticals (AMRX) EBITDA Margin (2017 - 2026)
Amneal Pharmaceuticals (AMRX) recorded EBITDA Margin of 22.30% in Q2 2026, down 1.37 percentage points from 23.67% a year earlier and down 3.30 percentage points from the prior quarter.
Powered by 
Analysis
Amneal Pharmaceuticals (AMRX) EBITDA Margin (2017 - 2026) Analysis & Trends
On a TTM basis, Amneal Pharmaceuticals' EBITDA Margin came in at 20.79% as of Jun 30, 2026, down 1.00 percentage points year-over-year; for FY2025, it was 20.46%, up 3.08 percentage points from FY2024.
- Annual EBITDA Margin has a five-year change of +4.07 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at 17.38% in FY2024 (-0.74 pp), 18.12% in FY2023 (+11.56 pp), 6.57% in FY2022 (-11.88 pp) and 18.44% in FY2021 (+2.05 pp).
- Quarterly EBITDA Margin has ranged from -24.84% in Q2 2022 to 25.60% in Q1 2026 over the past five years.
- On a year-over-year basis, EBITDA Margin rose in five of the last eight quarters, with an average year-over-year change of +2.79 percentage points.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 47.74 percentage points in Q2 2023, against a drop of 47.94 percentage points in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at 25.60% (Q1 2026), 19.80% (Q4 2025) and 15.86% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,155.65 Bn | 1,124.24 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 623.71 Bn | 542.24 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 512.92 Bn | 486.03 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 365.46 Bn | 319.84 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 297.38 Bn | 261.37 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.52 Bn | 235.20 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 235.15 Bn | 190.55 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 193.26 Bn | 167.45 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 171.63 Bn | 118.27 Bn | 10.94 Bn | 39.16% |
| 10 | Amneal Pharmaceuticals | 6.28 Bn | 5.47 Bn | 334.51 Mn | 22.81% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.81% |
| Mar 31, 2026 | 26.14% |
| Dec 31, 2025 | 20.26% |
| Sep 30, 2025 | 16.50% |
| Jun 30, 2025 | 24.62% |
| Mar 31, 2025 | 24.06% |
| Dec 31, 2024 | 20.36% |
| Sep 30, 2024 | 22.18% |
| Jun 30, 2024 | 22.58% |
| Mar 31, 2024 | 7.83% |
| Dec 31, 2023 | 12.28% |
| Sep 30, 2023 | 21.81% |
| Jun 30, 2023 | 23.31% |
| Mar 31, 2023 | 16.98% |
| Dec 31, 2022 | 16.27% |
| Sep 30, 2022 | 19.81% |
| Jun 30, 2022 | -24.44% |
| Mar 31, 2022 | 16.74% |
| Dec 31, 2021 | 13.91% |
| Sep 30, 2021 | 17.23% |
API Access
Amneal Pharmaceuticals EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=AMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "AMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=AMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();